Drug recall · October 20, 2021
Potassium Chloride Extended-Release Tablets recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07.
- Lots / codes
Lot 7240840A, exp. 12/31/2021
- Quantity
- 1813 bottles
- Company
- Strides Pharma Inc., East Brunswick, NJ
- Distribution
- Nationwide
- Initiated
- September 27, 2021 · Voluntary: Firm initiated
- Classified
- October 8, 2021
- Reported
- October 20, 2021
- Ended
- October 26, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Potassium chloride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.